Anti-phospholipid Antibody syndrome is Characterized by all except
**Core Concept**
Anti-phospholipid Antibody Syndrome (APS) is a condition characterized by the presence of antiphospholipid antibodies (aPL), leading to clinical manifestations such as thrombosis, pregnancy complications, and other systemic features. These antibodies target phospholipid-binding proteins, including beta-2 glycoprotein I, and are associated with a hypercoagulable state.
**Why the Correct Answer is Right**
Central nervous system (CNS) involvement in APS is more common than previously thought, and can manifest as various neurological symptoms, including migraines, seizures, and stroke. The presence of aPL has been linked to an increased risk of CNS thrombosis, which can be catastrophic. The incorrect statement underestimates the frequency and severity of CNS involvement in APS. The pathophysiology of CNS involvement in APS is not fully understood, but it is thought to be related to the binding of aPL to endothelial cells and the subsequent activation of the coagulation cascade.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because antibodies directed against phospholipid-binding proteins, such as beta-2 glycoprotein I, are a hallmark of APS. These antibodies are responsible for the clinical manifestations of the syndrome.
**Option B:** Incorrect because inhibition of syncytiotrophoblast differentiation is a key mechanism underlying the pregnancy complications associated with APS. The presence of aPL can interfere with placental development and function, leading to recurrent miscarriage and other pregnancy-related problems.
**Option D:** Incorrect because high-risk placental infarction and early-onset pre-eclampsia are indeed characteristic features of APS. The presence of aPL can lead to placental thrombosis and dysfunction, resulting in these serious pregnancy complications.
**Clinical Pearl / High-Yield Fact**
APS is a critical consideration in the evaluation of women with recurrent pregnancy loss, pre-eclampsia, or unexplained thrombosis. The presence of aPL can have significant implications for treatment and management, including the use of anticoagulation therapy and immunosuppressive medications.
**β Correct Answer: C. Central nervous system involvement is least common.**